270 related articles for article (PubMed ID: 23112834)
1. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
[TBL] [Abstract][Full Text] [Related]
2. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
3. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
[TBL] [Abstract][Full Text] [Related]
4. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
[TBL] [Abstract][Full Text] [Related]
5. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
[TBL] [Abstract][Full Text] [Related]
6. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
[TBL] [Abstract][Full Text] [Related]
8. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
9. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.
Wen CP; Lin J; Yang YC; Tsai MK; Tsao CK; Etzel C; Huang M; Hsu CY; Ye Y; Mishra L; Hawk E; Wu X
J Natl Cancer Inst; 2012 Oct; 104(20):1599-611. PubMed ID: 23073549
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
12. Serum liver enzymes are associated with all-cause mortality in an elderly population.
Koehler EM; Sanna D; Hansen BE; van Rooij FJ; Heeringa J; Hofman A; Tiemeier H; Stricker BH; Schouten JN; Janssen HL
Liver Int; 2014 Feb; 34(2):296-304. PubMed ID: 24219360
[TBL] [Abstract][Full Text] [Related]
13. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
Ju MJ; Qiu SJ; Fan J; Zhou J; Gao Q; Cai MY; Li YW; Tang ZY
J Gastroenterol; 2009; 44(6):635-42. PubMed ID: 19387533
[TBL] [Abstract][Full Text] [Related]
15. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
[TBL] [Abstract][Full Text] [Related]
16. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Kunutsor SK; Apekey TA; Khan H
Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma.
Zhang LX; Lv Y; Xu AM; Wang HZ
BMC Cancer; 2019 Aug; 19(1):841. PubMed ID: 31455253
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
20. Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan.
Suruki R; Hayashi K; Kusumoto K; Uto H; Ido A; Tsubouchi H; Stuver SO
Int J Cancer; 2006 Jul; 119(1):192-5. PubMed ID: 16432841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]